
NR0B2 antibody immunohistochemistry of formalin-fixed and paraffin-embedded human hepatocarcinoma followed by peroxidase-conjugated secondary antibody and DAB staining.

NR0B2 Antibody (PEI 1:100) western blot of HepG2 cell line lysates (35 ug/lane). The NR0B2 antibody detected the NR0B2 protein (arrow).

NR0B2 Antibody flow cytometry of HepG2 cells (right histogram) compared to a negative control cell (left histogram). FITC-conjugated goat-anti-rabbit secondary antibodies were used for the analysis.